Context Therapeutics (CNTX) Interest Coverage Ratio (2020 - 2026)

Context Therapeutics (CNTX) posted Interest Coverage Ratio of 0.99 for Q1 2026, up 78.97% sequentially from 4.69 in Q4 2025.

Context Therapeutics (CNTX) Interest Coverage Ratio (2020 - 2026) Analysis & Trends

Context Therapeutics has reported Interest Coverage Ratio for 7 years, with the latest figure at 0.99 in Q1 2026.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 0.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.6 (changed N/A YoY) and the FY2025 annual result came in at 1.11, up 8.5% from the prior year.
Interest Coverage Ratio rose to 0.99 in Q1 2026 per CNTX's latest filing, from 4.69 in the prior quarter.
Over five years, Interest Coverage Ratio peaked at 0.17 in Q4 2024 and troughed at 4611.7 in Q2 2025.
A 5-year average of 389.61 and a median of 5.11 in 2024 frame the typical range for Interest Coverage Ratio.
The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio soared 99.69% in 2022, then tumbled 271072.45% in 2025.
Over 5 years, Interest Coverage Ratio stood at 0.42 in 2022, then grew by 1.15% to 0.42 in 2023, then soared by 58.3% to 0.17 in 2024, then plunged by 2595.57% to 4.69 in 2025, then jumped by 78.97% to 0.99 in 2026.
According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.99, 4.69, and 14.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	138.54 Bn	130.69 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.89 Bn	77.89 Bn	3.93 Bn	117.59
3	Argenx Se	64.84 Bn	59.65 Bn	1.37 Bn	-
4	Moderna	56.53 Bn	51.39 Bn	52.00 Mn	-
5	BeOne Medicines	41.97 Bn	36.87 Bn	1.53 Bn	8.18
6	Alnylam Pharmaceuticals	31.53 Bn	28.22 Bn	992.69 Mn	2.82
7	BioNTech SE	27.70 Bn	9.31 Bn	668.28 Mn	76.86
8	Insmed	27.45 Bn	26.29 Bn	358.27 Mn	-0.08
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	1.42
10	Context Therapeutics	48.50 Mn	48.50 Mn	-	-

Download Data